From
WebMD:
The FDA has approved the first generic versions of the drugs Zyprexa and Zyprexa Zydis for the treatment of schizophrenia and bipolar disorder. The generic name for the two drugs is
olanzapine.
Keith Webber, PhD, deputy director of the FDA's Office of Pharmaceutical Science, says the approval of generic olanzapine "offers greater access to a widely used treatment for mental illness."
He says that having "affordable treatment options is good for patients with long-term illnesses that must be carefully managed."
Zyprexa can cost more than $300 a month, while generic versions can substantially cut the cost.
The FDA says olanzapine must be dispensed with a medication guide that describes the risks and possible adverse reactions patients may experience. Olanzapine is not approved for treating psychosis in the elderly with dementia.
The drug can have side effects leading to high blood sugar and high blood fat levels and weight gain.